Newsfeeds - Spark Newswire

1 minute read

INmune Bio, Inc. To Provide Additional Manufacturing Information To FDA As Part Of IND Application For XPro1595 In Alzheimer’s Disease

Today, 10:06 PM

INmune Bio, Inc. (NASDAQ:INMB) (the "Company"), a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, today announced

INMB

30 minute read

Earnings Scheduled For May 5, 2022

By Benzinga Insights

Today, 10:06 PM

Companies Reporting Before The Bell • Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.

AAOI

4 minute read

60 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:06 PM

Gainers

AGE

4 minute read

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron’s COVID-19 Therapy Decision Pushed, Protagonist’s Rusfertide Breakthrough Tag Update And More

By Vandana Singh

Today, 10:06 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ABBV

1 minute read

INmune Bio Reports First Patient Dosed In Phase 2 XPro1595 Trial For Treatment Of Neuroinflammation As Cause Of Alzheimer’s

By Benzinga Newsdesk

Today, 10:06 PM

INmune Bio, Inc. (NASDAQ:INMB) (“INMB” or “the Company”), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune

INMB

4 minute read

63 Biggest Movers From Yesterday

By Lisa Levin

Today, 10:06 PM

Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire.

ADN

2 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

Today, 10:06 PM

Gainers

BIMI

27 minute read

Stocks That Hit 52-Week Lows On Tuesday

By Benzinga Insights

Today, 10:06 PM

During Tuesday's session, 454 stocks hit new 52-week lows.

ADAG

10 minute read

Stocks That Hit 52-Week Lows On Thursday

By Benzinga Insights

Today, 10:06 PM

During Thursday, 166 stocks hit new 52-week lows.

ACMR

9 minute read

Earnings Scheduled For March 3, 2022

By Benzinga Insights

Today, 10:06 PM

Companies Reporting Before The Bell • Travelzoo (NASDAQ:TZOO) is expected to report quarterly earnings at $0.13 per share on revenue of $18.23 million.

ABUS